ASCEND CSP IDE Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 414 participants.

Also called NCT06830746

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 414 participants (planned count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06830746
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, Canada, France, Hong Kong SAR China, India, Italy, Singapore, Spain, Switzerland (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06830746. Allocation not applicable; no masking; primary purpose treatment. Start 2025-04-11 (actual); primary completion 2026-01-29 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ASCEND CSP IDE Study
Acronym
ASCEND CSP IDE
Condition
Heart Failure
Condition
Ventricular Arrythmia
Intervention (Device)
LBBAP Implant with a CSP ICD Lead
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct06830746
Content hash
acf2512382b36fddcc86f1a9e3a4031c481373a12cebebbb8798b19d1761e2eb